Home / Market Reports / Medical Care / Global Neutropenia Biologic Drug Treatment Market Growth (Status and Outlook) 2024-2030

Global Neutropenia Biologic Drug Treatment Market Growth (Status and Outlook) 2024-2030

: Product Code:850800

Published Date: Jan 12,2024

Pages: 129

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

Single User License

$3660.00

Multi User License

$5490.00

Corporate Users License

$7320.00

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

According to our LPI (LP Information) latest study, the global Neutropenia Biologic Drug Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Neutropenia Biologic Drug Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Neutropenia Biologic Drug Treatment market. Neutropenia Biologic Drug Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neutropenia Biologic Drug Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neutropenia Biologic Drug Treatment market.

Neutropenia is a clinical condition characterized by a decrease in neutrophil count in the blood, resulting in a higher risk of developing serious infections. A neutrophil is a type of white blood cell, which helps in fighting infections. The major causes of neutropenia include cancer chemotherapy, infections, bone marrow disorders, autoimmune disorders, and the use of specific drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:
The report on Neutropenia Biologic Drug Treatment market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Neutropenia Biologic Drug Treatment market. It may include historical data, market segmentation by Type (e.g., Filgrastim, Pegfilgrastim), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neutropenia Biologic Drug Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Neutropenia Biologic Drug Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Neutropenia Biologic Drug Treatment industry. This include advancements in Neutropenia Biologic Drug Treatment technology, Neutropenia Biologic Drug Treatment new entrants, Neutropenia Biologic Drug Treatment new investment, and other innovations that are shaping the future of Neutropenia Biologic Drug Treatment.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neutropenia Biologic Drug Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Neutropenia Biologic Drug Treatment product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neutropenia Biologic Drug Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neutropenia Biologic Drug Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neutropenia Biologic Drug Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neutropenia Biologic Drug Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neutropenia Biologic Drug Treatment market.

Market Segmentation:
Neutropenia Biologic Drug Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
By Drug Type
Filgrastim
Pegfilgrastim
Lenograstim
Lipegfilgrastim
Sargramostim
By Treatment Type
Antibiotic Drugs
Granulocyte-Colony-Stimulating Factor (G-CSF)
Antifungal Drugs
Others

Segmentation by application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva Pharmaceutical
Amgen
Sanofi
Mylan(Fulphila)
Kyowa Kirin
Novartis
Spectrum Pharmaceuticals
Pfizer
Baxter International
Partner Therapeutics(Leukine)
BeyondSpring Pharmaceuticals
Cellerant Therapeutics
Enzychem Lifesciences Corporation
Myelo Therapeutics
Generon

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neutropenia Biologic Drug Treatment Market Size 2019-2030
2.1.2 Neutropenia Biologic Drug Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neutropenia Biologic Drug Treatment Segment by Type
2.2.1 Filgrastim
2.2.2 Pegfilgrastim
2.2.3 Lenograstim
2.2.4 Lipegfilgrastim
2.2.5 Sargramostim
2.3 Neutropenia Biologic Drug Treatment Market Size by Type
2.3.1 Neutropenia Biologic Drug Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2019-2024)
2.4 Neutropenia Biologic Drug Treatment Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Online Pharmacies
2.5 Neutropenia Biologic Drug Treatment Market Size by Application
2.5.1 Neutropenia Biologic Drug Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2019-2024)

3 Neutropenia Biologic Drug Treatment Market Size by Player
3.1 Neutropenia Biologic Drug Treatment Market Size Market Share by Players
3.1.1 Global Neutropenia Biologic Drug Treatment Revenue by Players (2019-2024)
3.1.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Neutropenia Biologic Drug Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Neutropenia Biologic Drug Treatment by Regions
4.1 Neutropenia Biologic Drug Treatment Market Size by Regions (2019-2024)
4.2 Americas Neutropenia Biologic Drug Treatment Market Size Growth (2019-2024)
4.3 APAC Neutropenia Biologic Drug Treatment Market Size Growth (2019-2024)
4.4 Europe Neutropenia Biologic Drug Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Growth (2019-2024)

5 Americas
5.1 Americas Neutropenia Biologic Drug Treatment Market Size by Country (2019-2024)
5.2 Americas Neutropenia Biologic Drug Treatment Market Size by Type (2019-2024)
5.3 Americas Neutropenia Biologic Drug Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Neutropenia Biologic Drug Treatment Market Size by Region (2019-2024)
6.2 APAC Neutropenia Biologic Drug Treatment Market Size by Type (2019-2024)
6.3 APAC Neutropenia Biologic Drug Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Neutropenia Biologic Drug Treatment by Country (2019-2024)
7.2 Europe Neutropenia Biologic Drug Treatment Market Size by Type (2019-2024)
7.3 Europe Neutropenia Biologic Drug Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Neutropenia Biologic Drug Treatment by Region (2019-2024)
8.2 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Global Neutropenia Biologic Drug Treatment Market Forecast
10.1 Global Neutropenia Biologic Drug Treatment Forecast by Regions (2025-2030)
10.1.1 Global Neutropenia Biologic Drug Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Neutropenia Biologic Drug Treatment Forecast
10.1.3 APAC Neutropenia Biologic Drug Treatment Forecast
10.1.4 Europe Neutropenia Biologic Drug Treatment Forecast
10.1.5 Middle East & Africa Neutropenia Biologic Drug Treatment Forecast
10.2 Americas Neutropenia Biologic Drug Treatment Forecast by Country (2025-2030)
10.2.1 United States Neutropenia Biologic Drug Treatment Market Forecast
10.2.2 Canada Neutropenia Biologic Drug Treatment Market Forecast
10.2.3 Mexico Neutropenia Biologic Drug Treatment Market Forecast
10.2.4 Brazil Neutropenia Biologic Drug Treatment Market Forecast
10.3 APAC Neutropenia Biologic Drug Treatment Forecast by Region (2025-2030)
10.3.1 China Neutropenia Biologic Drug Treatment Market Forecast
10.3.2 Japan Neutropenia Biologic Drug Treatment Market Forecast
10.3.3 Korea Neutropenia Biologic Drug Treatment Market Forecast
10.3.4 Southeast Asia Neutropenia Biologic Drug Treatment Market Forecast
10.3.5 India Neutropenia Biologic Drug Treatment Market Forecast
10.3.6 Australia Neutropenia Biologic Drug Treatment Market Forecast
10.4 Europe Neutropenia Biologic Drug Treatment Forecast by Country (2025-2030)
10.4.1 Germany Neutropenia Biologic Drug Treatment Market Forecast
10.4.2 France Neutropenia Biologic Drug Treatment Market Forecast
10.4.3 UK Neutropenia Biologic Drug Treatment Market Forecast
10.4.4 Italy Neutropenia Biologic Drug Treatment Market Forecast
10.4.5 Russia Neutropenia Biologic Drug Treatment Market Forecast
10.5 Middle East & Africa Neutropenia Biologic Drug Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Neutropenia Biologic Drug Treatment Market Forecast
10.5.2 South Africa Neutropenia Biologic Drug Treatment Market Forecast
10.5.3 Israel Neutropenia Biologic Drug Treatment Market Forecast
10.5.4 Turkey Neutropenia Biologic Drug Treatment Market Forecast
10.5.5 GCC Countries Neutropenia Biologic Drug Treatment Market Forecast
10.6 Global Neutropenia Biologic Drug Treatment Forecast by Type (2025-2030)
10.7 Global Neutropenia Biologic Drug Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Information
11.1.2 Teva Pharmaceutical Neutropenia Biologic Drug Treatment Product Offered
11.1.3 Teva Pharmaceutical Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Teva Pharmaceutical Main Business Overview
11.1.5 Teva Pharmaceutical Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Neutropenia Biologic Drug Treatment Product Offered
11.2.3 Amgen Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Neutropenia Biologic Drug Treatment Product Offered
11.3.3 Sanofi Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Mylan(Fulphila)
11.4.1 Mylan(Fulphila) Company Information
11.4.2 Mylan(Fulphila) Neutropenia Biologic Drug Treatment Product Offered
11.4.3 Mylan(Fulphila) Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Mylan(Fulphila) Main Business Overview
11.4.5 Mylan(Fulphila) Latest Developments
11.5 Kyowa Kirin
11.5.1 Kyowa Kirin Company Information
11.5.2 Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offered
11.5.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Kyowa Kirin Main Business Overview
11.5.5 Kyowa Kirin Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Neutropenia Biologic Drug Treatment Product Offered
11.6.3 Novartis Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Spectrum Pharmaceuticals
11.7.1 Spectrum Pharmaceuticals Company Information
11.7.2 Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Product Offered
11.7.3 Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Spectrum Pharmaceuticals Main Business Overview
11.7.5 Spectrum Pharmaceuticals Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Neutropenia Biologic Drug Treatment Product Offered
11.8.3 Pfizer Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Baxter International
11.9.1 Baxter International Company Information
11.9.2 Baxter International Neutropenia Biologic Drug Treatment Product Offered
11.9.3 Baxter International Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Baxter International Main Business Overview
11.9.5 Baxter International Latest Developments
11.10 Partner Therapeutics(Leukine)
11.10.1 Partner Therapeutics(Leukine) Company Information
11.10.2 Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Product Offered
11.10.3 Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Partner Therapeutics(Leukine) Main Business Overview
11.10.5 Partner Therapeutics(Leukine) Latest Developments
11.11 BeyondSpring Pharmaceuticals
11.11.1 BeyondSpring Pharmaceuticals Company Information
11.11.2 BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Product Offered
11.11.3 BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 BeyondSpring Pharmaceuticals Main Business Overview
11.11.5 BeyondSpring Pharmaceuticals Latest Developments
11.12 Cellerant Therapeutics
11.12.1 Cellerant Therapeutics Company Information
11.12.2 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offered
11.12.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cellerant Therapeutics Main Business Overview
11.12.5 Cellerant Therapeutics Latest Developments
11.13 Enzychem Lifesciences Corporation
11.13.1 Enzychem Lifesciences Corporation Company Information
11.13.2 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offered
11.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Enzychem Lifesciences Corporation Main Business Overview
11.13.5 Enzychem Lifesciences Corporation Latest Developments
11.14 Myelo Therapeutics
11.14.1 Myelo Therapeutics Company Information
11.14.2 Myelo Therapeutics Neutropenia Biologic Drug Treatment Product Offered
11.14.3 Myelo Therapeutics Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Myelo Therapeutics Main Business Overview
11.14.5 Myelo Therapeutics Latest Developments
11.15 Generon
11.15.1 Generon Company Information
11.15.2 Generon Neutropenia Biologic Drug Treatment Product Offered
11.15.3 Generon Neutropenia Biologic Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Generon Main Business Overview
11.15.5 Generon Latest Developments

12 Research Findings and Conclusion

List of Tables
    Table 1. Neutropenia Biologic Drug Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
    Table 2. Major Players of Filgrastim
    Table 3. Major Players of Pegfilgrastim
    Table 4. Major Players of Lenograstim
    Table 5. Major Players of Lipegfilgrastim
    Table 6. Major Players of Sargramostim
    Table 7. Neutropenia Biologic Drug Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
    Table 8. Global Neutropenia Biologic Drug Treatment Market Size by Type (2019-2024) & ($ Millions)
    Table 9. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2019-2024)
    Table 10. Neutropenia Biologic Drug Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
    Table 11. Global Neutropenia Biologic Drug Treatment Market Size by Application (2019-2024) & ($ Millions)
    Table 12. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2019-2024)
    Table 13. Global Neutropenia Biologic Drug Treatment Revenue by Players (2019-2024) & ($ Millions)
    Table 14. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Player (2019-2024)
    Table 15. Neutropenia Biologic Drug Treatment Key Players Head office and Products Offered
    Table 16. Neutropenia Biologic Drug Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Neutropenia Biologic Drug Treatment Market Size by Regions 2019-2024 & ($ Millions)
    Table 20. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Regions (2019-2024)
    Table 21. Global Neutropenia Biologic Drug Treatment Revenue by Country/Region (2019-2024) & ($ millions)
    Table 22. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Country/Region (2019-2024)
    Table 23. Americas Neutropenia Biologic Drug Treatment Market Size by Country (2019-2024) & ($ Millions)
    Table 24. Americas Neutropenia Biologic Drug Treatment Market Size Market Share by Country (2019-2024)
    Table 25. Americas Neutropenia Biologic Drug Treatment Market Size by Type (2019-2024) & ($ Millions)
    Table 26. Americas Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2019-2024)
    Table 27. Americas Neutropenia Biologic Drug Treatment Market Size by Application (2019-2024) & ($ Millions)
    Table 28. Americas Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2019-2024)
    Table 29. APAC Neutropenia Biologic Drug Treatment Market Size by Region (2019-2024) & ($ Millions)
    Table 30. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Region (2019-2024)
    Table 31. APAC Neutropenia Biologic Drug Treatment Market Size by Type (2019-2024) & ($ Millions)
    Table 32. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2019-2024)
    Table 33. APAC Neutropenia Biologic Drug Treatment Market Size by Application (2019-2024) & ($ Millions)
    Table 34. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2019-2024)
    Table 35. Europe Neutropenia Biologic Drug Treatment Market Size by Country (2019-2024) & ($ Millions)
    Table 36. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Country (2019-2024)
    Table 37. Europe Neutropenia Biologic Drug Treatment Market Size by Type (2019-2024) & ($ Millions)
    Table 38. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2019-2024)
    Table 39. Europe Neutropenia Biologic Drug Treatment Market Size by Application (2019-2024) & ($ Millions)
    Table 40. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2019-2024)
    Table 41. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Region (2019-2024) & ($ Millions)
    Table 42. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Region (2019-2024)
    Table 43. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Type (2019-2024) & ($ Millions)
    Table 44. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2019-2024)
    Table 45. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Application (2019-2024) & ($ Millions)
    Table 46. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2019-2024)
    Table 47. Key Market Drivers & Growth Opportunities of Neutropenia Biologic Drug Treatment
    Table 48. Key Market Challenges & Risks of Neutropenia Biologic Drug Treatment
    Table 49. Key Industry Trends of Neutropenia Biologic Drug Treatment
    Table 50. Global Neutropenia Biologic Drug Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
    Table 51. Global Neutropenia Biologic Drug Treatment Market Size Market Share Forecast by Regions (2025-2030)
    Table 52. Global Neutropenia Biologic Drug Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
    Table 53. Global Neutropenia Biologic Drug Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
    Table 54. Teva Pharmaceutical Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 55. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Product Offered
    Table 56. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 57. Teva Pharmaceutical Main Business
    Table 58. Teva Pharmaceutical Latest Developments
    Table 59. Amgen Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 60. Amgen Neutropenia Biologic Drug Treatment Product Offered
    Table 61. Amgen Main Business
    Table 62. Amgen Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 63. Amgen Latest Developments
    Table 64. Sanofi Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 65. Sanofi Neutropenia Biologic Drug Treatment Product Offered
    Table 66. Sanofi Main Business
    Table 67. Sanofi Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 68. Sanofi Latest Developments
    Table 69. Mylan(Fulphila) Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 70. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Product Offered
    Table 71. Mylan(Fulphila) Main Business
    Table 72. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 73. Mylan(Fulphila) Latest Developments
    Table 74. Kyowa Kirin Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 75. Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offered
    Table 76. Kyowa Kirin Main Business
    Table 77. Kyowa Kirin Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 78. Kyowa Kirin Latest Developments
    Table 79. Novartis Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 80. Novartis Neutropenia Biologic Drug Treatment Product Offered
    Table 81. Novartis Main Business
    Table 82. Novartis Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 83. Novartis Latest Developments
    Table 84. Spectrum Pharmaceuticals Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 85. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Product Offered
    Table 86. Spectrum Pharmaceuticals Main Business
    Table 87. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 88. Spectrum Pharmaceuticals Latest Developments
    Table 89. Pfizer Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 90. Pfizer Neutropenia Biologic Drug Treatment Product Offered
    Table 91. Pfizer Main Business
    Table 92. Pfizer Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 93. Pfizer Latest Developments
    Table 94. Baxter International Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 95. Baxter International Neutropenia Biologic Drug Treatment Product Offered
    Table 96. Baxter International Main Business
    Table 97. Baxter International Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 98. Baxter International Latest Developments
    Table 99. Partner Therapeutics(Leukine) Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 100. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Product Offered
    Table 101. Partner Therapeutics(Leukine) Main Business
    Table 102. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 103. Partner Therapeutics(Leukine) Latest Developments
    Table 104. BeyondSpring Pharmaceuticals Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 105. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Product Offered
    Table 106. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 107. BeyondSpring Pharmaceuticals Main Business
    Table 108. BeyondSpring Pharmaceuticals Latest Developments
    Table 109. Cellerant Therapeutics Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 110. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offered
    Table 111. Cellerant Therapeutics Main Business
    Table 112. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 113. Cellerant Therapeutics Latest Developments
    Table 114. Enzychem Lifesciences Corporation Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 115. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offered
    Table 116. Enzychem Lifesciences Corporation Main Business
    Table 117. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 118. Enzychem Lifesciences Corporation Latest Developments
    Table 119. Myelo Therapeutics Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 120. Myelo Therapeutics Neutropenia Biologic Drug Treatment Product Offered
    Table 121. Myelo Therapeutics Main Business
    Table 122. Myelo Therapeutics Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 123. Myelo Therapeutics Latest Developments
    Table 124. Generon Details, Company Type, Neutropenia Biologic Drug Treatment Area Served and Its Competitors
    Table 125. Generon Neutropenia Biologic Drug Treatment Product Offered
    Table 126. Generon Main Business
    Table 127. Generon Neutropenia Biologic Drug Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 128. Generon Latest Developments
List of Figures
    Figure 1. Neutropenia Biologic Drug Treatment Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Neutropenia Biologic Drug Treatment Market Size Growth Rate 2019-2030 ($ Millions)
    Figure 6. Neutropenia Biologic Drug Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
    Figure 7. Neutropenia Biologic Drug Treatment Sales Market Share by Country/Region (2023)
    Figure 8. Neutropenia Biologic Drug Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
    Figure 9. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Type in 2023
    Figure 10. Neutropenia Biologic Drug Treatment in Retail Pharmacies
    Figure 11. Global Neutropenia Biologic Drug Treatment Market: Retail Pharmacies (2019-2024) & ($ Millions)
    Figure 12. Neutropenia Biologic Drug Treatment in Hospital Pharmacies
    Figure 13. Global Neutropenia Biologic Drug Treatment Market: Hospital Pharmacies (2019-2024) & ($ Millions)
    Figure 14. Neutropenia Biologic Drug Treatment in Online Pharmacies
    Figure 15. Global Neutropenia Biologic Drug Treatment Market: Online Pharmacies (2019-2024) & ($ Millions)
    Figure 16. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Application in 2023
    Figure 17. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Player in 2023
    Figure 18. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Regions (2019-2024)
    Figure 19. Americas Neutropenia Biologic Drug Treatment Market Size 2019-2024 ($ Millions)
    Figure 20. APAC Neutropenia Biologic Drug Treatment Market Size 2019-2024 ($ Millions)
    Figure 21. Europe Neutropenia Biologic Drug Treatment Market Size 2019-2024 ($ Millions)
    Figure 22. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size 2019-2024 ($ Millions)
    Figure 23. Americas Neutropenia Biologic Drug Treatment Value Market Share by Country in 2023
    Figure 24. United States Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 25. Canada Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 26. Mexico Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 27. Brazil Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 28. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Region in 2023
    Figure 29. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Type in 2023
    Figure 30. APAC Neutropenia Biologic Drug Treatment Market Size Market Share by Application in 2023
    Figure 31. China Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 32. Japan Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 33. Korea Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 34. Southeast Asia Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 35. India Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 36. Australia Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 37. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Country in 2023
    Figure 38. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2019-2024)
    Figure 39. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2019-2024)
    Figure 40. Germany Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 41. France Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 42. UK Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 43. Italy Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 44. Russia Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 45. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Region (2019-2024)
    Figure 46. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2019-2024)
    Figure 47. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Application (2019-2024)
    Figure 48. Egypt Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 49. South Africa Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 50. Israel Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 51. Turkey Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 52. GCC Country Neutropenia Biologic Drug Treatment Market Size Growth 2019-2024 ($ Millions)
    Figure 53. Americas Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 54. APAC Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 55. Europe Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 56. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 57. United States Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 58. Canada Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 59. Mexico Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 60. Brazil Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 61. China Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 62. Japan Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 63. Korea Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 64. Southeast Asia Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 65. India Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 66. Australia Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 67. Germany Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 68. France Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 69. UK Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 70. Italy Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 71. Russia Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 72. Spain Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 73. Egypt Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 74. South Africa Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 75. Israel Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 76. Turkey Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 77. GCC Countries Neutropenia Biologic Drug Treatment Market Size 2025-2030 ($ Millions)
    Figure 78. Global Neutropenia Biologic Drug Treatment Market Size Market Share Forecast by Type (2025-2030)
    Figure 79. Global Neutropenia Biologic Drug Treatment Market Size Market Share Forecast by Application (2025-2030)

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives

Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights

Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis

Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

RELATED REPORTS

31

Jan

2021

Global Neutropenia Biologic Drug Treatment Market Growth (Status and Outlook) 2021-2026

Pages: 131|Category: MEDICAL CARE

According to this latest study, the 2021 growth of Neutropenia Biologic Drug Treatment will have significant change from previous year. By the most conservative estimates of global Neutropenia Biologic Drug Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Neutropenia Biologic Drug Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

$3660.00

VIEW DETAILS